Which has the lower trailing P/E, DXCM or IQV?

IQV has the lower trailing P/E: DXCM trades at 34.93 and IQV at 33.50. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or IQV?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IQV at 5.61%.

Is DXCM or IQV more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus IQV at 8.10%.

How have DXCM and IQV total returns compared?

Over the past 10 years, DXCM delivered 13.57% and IQV delivered 13.00% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of DexCom, Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$33.35B

$88.38HealthcareDelayed quote: Sep 16, 2026, 11:05 AM EDT

IQV

IQVIA Holdings Inc.

$44.45B

$270.05HealthcareDelayed quote: Sep 16, 2026, 11:05 AM EDT

Total return — DXCM vs IQV

growth of $100 · dividends reinvested · last 10y

DXCM +261.5% (+13.7%/yr)IQV +236.2% (+12.9%/yr)DXCM compounded faster over this window

DXCM IQV

DXCM vs IQV: by the numbers

•IQV is the larger company ($44.45B vs $33.35B market cap).
•IQV trades at the lower trailing earnings multiple (33.50 vs 34.93 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 8.10% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 5.61% CAGR).

Metrics side by side

Valuation

Metric	DXCM	IQV
P/E ratio	34.93	33.50
Forward P/E	33.13	20.82
P/S ratio	6.71	2.62
P/B ratio	12.72	7.20
EV / EBITDA	23.98	16.85
FCF yield	4.21%	4.56%

Profitability

Metric	DXCM	IQV
Gross margin	62.47%	26.23%
Operating margin	22.92%	13.57%
Net margin	20.12%	8.10%
ROE	38.14%	22.28%
ROIC	21.71%	8.32%

Growth (annualized)

Metric	DXCM	IQV
Revenue CAGR (5Y)	18.03%	5.61%
EPS CAGR (5Y)	10.31%	40.21%
FCF CAGR (5Y)	69.49%	4.44%
Total return CAGR (5Y)	-9.57%	0.10%

Frequently asked

Which has the lower trailing P/E, DXCM or IQV?: IQV has the lower trailing P/E: DXCM trades at 34.93 and IQV at 33.50. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or IQV?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IQV at 5.61%.
Is DXCM or IQV more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus IQV at 8.10%.
How have DXCM and IQV total returns compared?: Over the past 10 years, DXCM delivered 13.57% and IQV delivered 13.00% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio IQVIA P/E ratio DexCom ROE IQVIA ROE DexCom operating margin IQVIA operating margin DexCom revenue growth IQVIA revenue growth DexCom free cash flow IQVIA free cash flow

DexCom & IQVIA appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.